A detailed history of Advisor Group Holdings, Inc. transactions in Avita Medical, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 373 shares of RCEL stock, worth $4,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares
373
Previous 373 -0.0%
Holding current value
$4,457
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$7.92 - $15.55 $23,918 - $46,961
-3,020 Reduced 89.01%
373 $2,000
Q1 2024

May 10, 2024

BUY
$12.56 - $18.31 $1,770 - $2,581
141 Added 4.34%
3,393 $54,000
Q4 2023

Feb 12, 2024

SELL
$9.29 - $14.57 $3,558 - $5,580
-383 Reduced 10.54%
3,252 $44,000
Q3 2023

Nov 13, 2023

BUY
$13.84 - $20.79 $802 - $1,205
58 Added 1.62%
3,635 $53,000
Q2 2023

Aug 10, 2023

BUY
$10.7 - $17.48 $1,765 - $2,884
165 Added 4.84%
3,577 $60,000
Q1 2023

May 12, 2023

BUY
$6.45 - $14.48 $4,869 - $10,932
755 Added 28.42%
3,412 $47,000
Q4 2022

Feb 10, 2023

BUY
$4.53 - $7.55 $11,388 - $18,980
2,514 Added 1758.04%
2,657 $17,000
Q3 2022

Nov 14, 2022

SELL
$4.97 - $7.89 $4,970 - $7,890
-1,000 Reduced 87.49%
143 $1,000
Q2 2022

Aug 10, 2022

SELL
$4.6 - $8.82 $459 - $882
-100 Reduced 8.05%
1,143 $6,000
Q1 2022

May 04, 2022

SELL
$6.96 - $12.15 $208 - $364
-30 Reduced 2.36%
1,243 $10,000
Q1 2021

May 13, 2021

SELL
$18.38 - $28.41 $23,030 - $35,597
-1,253 Reduced 49.6%
1,273 $25,000
Q4 2020

Feb 10, 2021

BUY
$17.55 - $27.2 $6,844 - $10,608
390 Added 18.26%
2,526 $47,000
Q3 2020

Nov 12, 2020

BUY
$20.83 - $30.0 $2,499 - $3,600
120 Added 5.95%
2,136 $54,000
Q2 2020

Aug 14, 2020

BUY
$26.1 - $34.6 $52,617 - $69,753
2,016 New
2,016 $62,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $299M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.